Hydroxychloroquinesulfaat Focus

Hydroxychloroquine Sulfate, the active ingredient in Hydroxychloroquinesulfaat Focus, is an antimalarial presented as an oral dosage form for oral use. It is employed in the prevention and treatment of malaria and in the management of autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus.

GNH USA supplies Hydroxychloroquinesulfaat Focus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydroxychloroquine Sulfate is used in the management of parasitic infections and autoimmune disorders. - Malaria prophylaxis: prevents malaria infection in travelers and residents of endemic areas. - Malaria treatment: clears blood‑stage Plasmodium parasites during acute infection. - Rheumatoid arthritis: reduces joint inflammation and disease activity. - Systemic lupus erythematosus: controls disease flares and organ involvement.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Dizziness: occasional vertiginous sensations. - Abdominal pain: intermittent stomach discomfort. - Rash: mild skin erythema. - Visual disturbances: blurred vision or photophobia.

Serious or Rare Side Effects: - Retinopathy: progressive vision loss requiring ophthalmologic monitoring. - Cardiomyopathy: cardiac dysfunction with potential arrhythmias. - Severe hypoglycemia: especially in patients on antidiabetic agents. - Blood dyscrasias: agranulocytosis or aplastic anemia. - Stevens‑Johnson syndrome: severe skin reactions. - Neuropsychiatric effects: mood changes or psychosis.

Before initiating therapy, clinicians should assess patient‑specific risk factors and monitor for toxicity. - Retinal monitoring: schedule baseline and periodic eye examinations. - Cardiac assessment: evaluate QT interval and cardiac history. - Blood glucose control: monitor for hypoglycemia, especially with insulin or sulfonylureas. - Hepatic/renal function: adjust dosing in impairment. - Hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Hydroxychloroquine Sulfate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - QT‑prolonging agents (e.g., quinidine, azithromycin): increase risk of arrhythmia. - Antidiabetic drugs (insulin, sulfonylureas): potentiate hypoglycemia. - CYP2D6 inhibitors (paroxetine, fluoxetine): raise hydroxychloroquine plasma levels.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce absorption. - NSAIDs: additive gastrointestinal irritation. - Warfarin: potential alteration of anticoagulant effect. - Digoxin: possible increase in serum concentrations.